Infertility, Female Clinical Trial
— MinipubertyOfficial title:
Turner Syndrome Minipuberty Study A Prospective, Descriptive Cohortstudy
Rationale: Due to accelerated germ cell loss, infertility is a major problem in girls with Turner syndrome (TS). Therefore, cryopreservation of ovarian tissue or oocytes before exhaustion of the ovarian reserve may preserve fertility in patients with TS. However, in the majority of females with TS , the ovarian reserve is exhausted before the age of menarche. Early markers indicating and predicting the ovarian reserve are necessary. During mid-childhood the hypothalamic-pituitary-gonadal (HPG) axis is quiescent and gonadotropins are usually unmeasurable. Nonetheless, this axis is active during infancy. Therefore, gonadotropins are measurable with peak values at 3 months of age and with lower (but still measurable) values at 9 months of age, in a period called the minipuberty. The aim of this study is to find markers of ovarian capacity, during the minipuberty, in order to predict ovarian reserve in the future. Objective: The hormonal range of LH, FSH, AMH, inhibin B, testosterone and estradiol in girls with TS during the minipuberty and the relation of the hormone serum levels with the karyotype. Study design: A prospective, cohort study with a duration of 3 years. Study population: Girls with a pre- or perinatal diagnosis TS who are born in a medical centre in the Netherlands during the duration of the study Main study parameters/endpoints: Serum levels of FSH, LH, AMH, inhibin B, testosterone and estradiol at the age of 3 and 9 months.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | December 1, 2024 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 1 Month to 3 Months |
Eligibility | Inclusion Criteria: In order to be eligible to participate in the TS group of this study, a subject must meet all of the following criteria: - A diagnosis of TS before the age of three months; - Girls with a diagnosis of classic TS or other variants (i.e. 45,X, 45,X/46XiXq, 45,X/46,XY, 45,X/46,XX, 45,X/47,XXX, 45,X/46,X,r(X), 46,XiXq, other); - Whose parents have agreed to participate in the study through a signed written informed consent form. In order to be eligible to participate in the control group of this study, a subject must meet all of the following criteria: - No diagnosis of TS or any other diagnosis that might affect the HPG axis; - Girls that will have a blood collection within their usual care at 3 months and at 9 months of age. - Whose parents have agreed to participate in the study through a signed informed consent form. Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Any other diagnosis besides TS that might affect the HPG axis; - Ovarian surgery in the medical history; - Critical illness; - The use of medication affecting the HPG axis (e.g. estrogen suppletion therapy) |
Country | Name | City | State |
---|---|---|---|
Denmark | Righospitalet, University of Copenhagen | Copenhagen | |
Germany | Universitätsklinikum der Ruhr-Universität Bochum | Bochum | |
Germany | Justus-Liebig Universität Giessen | Gießen | |
Germany | Universitätsklinikum Tübingen | Tübingen | |
Netherlands | Amsterdam University medical center | Amsterdam | |
Netherlands | University medical center Groningen | Groningen | |
Netherlands | Leiden University medical center | Leiden | |
Netherlands | Maastricht University medical center | Maastricht | |
Netherlands | Radboud University Medical Center | Nijmegen | Gelderland |
Netherlands | Erasmus University medical center | Rotterdam | |
Netherlands | University medical Center Utrecht | Utrecht | |
Poland | Medical university of Silesia | Katowice | |
Sweden | University hospital of Umea | Umeå |
Lead Sponsor | Collaborator |
---|---|
Radboud University Medical Center |
Denmark, Germany, Netherlands, Poland, Sweden,
Bernard V, Donadille B, Zenaty D, Courtillot C, Salenave S, Brac de la Perriere A, Albarel F, Fevre A, Kerlan V, Brue T, Delemer B, Borson-Chazot F, Carel JC, Chanson P, Leger J, Touraine P, Christin-Maitre S; CMERC Center for Rare Disease. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod. 2016 Apr;31(4):782-8. doi: 10.1093/humrep/dew012. Epub 2016 Feb 13. — View Citation
Borgstrom B, Hreinsson J, Rasmussen C, Sheikhi M, Fried G, Keros V, Fridstrom M, Hovatta O. Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab. 2009 Jan;94(1):74-80. doi: 10.1210/jc.2008-0708. Epub 2008 Oct 28. Erratum In: J Clin Endocrinol Metab. 2009 Apr;94(4):1478. Birgit, Borgstrom [corrected to Borgstrom, Birgit]; Julius, Hreinsson [corrected to Hreinsson, Julius]; Carsten, Rasmussen [corrected to Rasmussen, Carsten]; Maryam, Sheikhi [corrected to Sheikhi, Maryam]; Gabriel, Fried [corrected to Fried, Gabriel]; Vi. — View Citation
Bryman I, Sylven L, Berntorp K, Innala E, Bergstrom I, Hanson C, Oxholm M, Landin-Wilhelmsen K. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril. 2011 Jun 30;95(8):2507-10. doi: 10.1016/j.fertnstert.2010.12.039. Epub 2011 Jan 22. — View Citation
Burgoyne PS, Baker TG. Perinatal oocyte loss in XO mice and its implications for the aetiology of gonadal dysgenesis in XO women. J Reprod Fertil. 1985 Nov;75(2):633-45. doi: 10.1530/jrf.0.0750633. — View Citation
Fechner PY, Davenport ML, Qualy RL, Ross JL, Gunther DF, Eugster EA, Huseman C, Zagar AJ, Quigley CA; Toddler Turner Study Group. Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age. J Clin Endocrinol Metab. 2006 Dec;91(12):4896-902. doi: 10.1210/jc.2006-1157. Epub 2006 Sep 12. — View Citation
Huang JY, Tulandi T, Holzer H, Lau NM, Macdonald S, Tan SL, Chian RC. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: Case Report. Hum Reprod. 2008 Feb;23(2):336-9. doi: 10.1093/humrep/dem307. Epub 2007 Dec 2. — View Citation
Johannsen TH, Main KM, Ljubicic ML, Jensen TK, Andersen HR, Andersen MS, Petersen JH, Andersson AM, Juul A. Sex Differences in Reproductive Hormones During Mini-Puberty in Infants With Normal and Disordered Sex Development. J Clin Endocrinol Metab. 2018 Aug 1;103(8):3028-3037. doi: 10.1210/jc.2018-00482. — View Citation
Lanciotti L, Cofini M, Leonardi A, Penta L, Esposito S. Up-To-Date Review About Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life. Front Endocrinol (Lausanne). 2018 Jul 23;9:410. doi: 10.3389/fendo.2018.00410. eCollection 2018. — View Citation
Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J Clin Endocrinol Metab. 1997 Jun;82(6):1810-3. doi: 10.1210/jcem.82.6.3970. — View Citation
Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006 Oct;91(10):3897-902. doi: 10.1210/jc.2006-0558. Epub 2006 Jul 18. — View Citation
Sutton EJ, McInerney-Leo A, Bondy CA, Gollust SE, King D, Biesecker B. Turner syndrome: four challenges across the lifespan. Am J Med Genet A. 2005 Dec 1;139A(2):57-66. doi: 10.1002/ajmg.a.30911. — View Citation
* Note: There are 11 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Defining the LH range in blood during minipuberty in girls with TS at 3 months of age and at 9 months of age | LH (luteinizing hormone) will be collected with a venapuncture and analysed with the Elecsys method on the Cobas E801system of Roche. | 1 year after venapuncture | |
Primary | Defining the FSH range during minipuberty in girls with TS at 3 months of age and at 9 months of age | FSH (follicle stimulating hormone) will be collected with a venapuncture and analysed with the Elecsys method on the Cobas E801system of Roche. | 1 year after venapuncture | |
Primary | Defining the AMH range during minipuberty in girls with TS at 3 months of age and at 9 months of age | AMH (Anti-Müllerian hormone) will be collected with a venapuncture and analysed on the Access of Beckman Coulter. | 1 year after venapuncture | |
Primary | Defining the estradiol range during minipuberty in girls with TS at 3 months of age and at 9 months of age | estradiol will be collected with a venapuncture and analysed with the LCMSMS analysis method. | 1 year after venapuncture | |
Primary | Defining the testosterone range during minipuberty in girls with TS at 3 months of age and at 9 months of age | testosterone will be collected with a venapuncture and analysed with the LCMSMS analysis method. | 1 year | |
Primary | Defining the inhibin B range during minipuberty in girls with TS at 3 months of age and at 9 months of age | inhibin B will be collected with a venapuncture and analysed with the GEN II ELISEA of Beckman Coulter. | 1 year after venapuncture | |
Secondary | Patient's karyotype vs LH | The association between patient's karyotype and LH level at 3 months of age and 9 months of age | 1 year after venapuncture | |
Secondary | Patient's karyotype vs FSH | The association between patient's karyotype and FSH level at 3 months of age and 9 months of age | 1 year after venapuncture | |
Secondary | Patient's karyotype vs AMH | The association between patient's karyotype and AMH level at 3 months of age and 9 months of age | 1 year after venapuncture | |
Secondary | Patient's karyotype vs estradiol | The association between patient's karyotype and estradiol level at 3 months of age and 9 months of age | 1 year after venapuncture | |
Secondary | Patient's karyotype vs testosterone | The association between patient's karyotype and testosterone level at 3 months of age and 9 months of age | 1 year after venapuncture | |
Secondary | Patient's karyotype vs inhibin B | The association between patient's karyotype and inhibin B level at 3 months of age and 9 months of age | 1 year after venapuncture |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05969574 -
Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
|
||
Recruiting |
NCT05358483 -
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Completed |
NCT03177538 -
Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders
|
Phase 4 | |
Completed |
NCT03638856 -
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
|
N/A | |
Completed |
NCT04052464 -
The Study of the Implantation Window From Endometrial Biopsy With Gene Expression Methods
|
||
Withdrawn |
NCT04753736 -
Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC
|
N/A | |
Completed |
NCT03349905 -
Deferred Versus Fresh Embryo Transfers
|
N/A | |
Completed |
NCT05076981 -
Progesterone Levels During Ovulation and Luteal Phase
|
||
Completed |
NCT04096027 -
Cabergoline Before or After Oocyte Collection for Follicular Resolution
|
Phase 4 | |
Recruiting |
NCT05980091 -
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
|
Phase 1 | |
Terminated |
NCT01933633 -
Improved Fertility After Exercise in Overweight/Obese Women
|
N/A | |
Terminated |
NCT01202643 -
Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF
|
Phase 1/Phase 2 | |
Completed |
NCT01202656 -
Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)
|
Phase 1/Phase 2 | |
Completed |
NCT01408615 -
A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)
|
||
Enrolling by invitation |
NCT05698550 -
The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
|
Phase 3 | |
Not yet recruiting |
NCT03910582 -
Personalized FET in RIF Patients With Displaced Dating
|
N/A | |
Completed |
NCT05440019 -
Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration
|
||
Completed |
NCT05130125 -
Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer
|